Please assess the completion status of the following clinical trial:

Trial Title: Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. age \>18,~2. a history of endoscopically proven gastroduodenal ulcer bleeding,~3. H. pylori negative~4. a history of cardiothrombotic disease requiring ASA, and~5. anticipated regular use of NSAIDs for the duration of trial~Exclusion Criteria:~1. concomitant use of anticoagulants;~2. a history of gastric or duodenal surgery other than a patch repair;~3. the presence of erosive esophagitis,~4. gastric outlet obstruction,~5. renal failure (defined by a serum creatinine level of more than 200 umol/L),~6. pregnancy,~7. terminal illness, or~8. cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- NSAID #1 (Type: ACTIVE_COMPARATOR): Celecoxib and Naproxen Placebo
- NSAID #2 (Type: ACTIVE_COMPARATOR): Naproxen and Celecoxib Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).